Sermorelin and Tesamorelin Interaction

Monitor
Researched 90% confidence

Sermorelin and Tesamorelin have an interaction requiring monitoring for interaction with 90% confidence. Similar mechanism; risk of excessive effects at higher doses. Both compounds affect the gi tract and pituitary, so monitoring these systems is recommended.

Compound Profiles

Sermorelin

GHRH Analog | Growth Hormone Releasing Hormone

Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..

Half-life: 10-12 minutes Typical dose: 200-300mcg per dose (up to 500mcg for athletic performance) growth hormone, weight loss
estrogen receptorghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Tesamorelin

GHRH Analog | Visceral Fat Reduction

Subcutaneous injection provides optimal bioavailability for GHRH receptor binding and pulsatile GH release stimulation, selectively targeting visceral adipose tissue while sparing subcutaneous fat..

Half-life: 26-38 minutes Typical dose: 1.4-2mg daily (FDA-approved: 2mg for HIV lipodystrophy) growth hormone, weight loss
ghrh receptor carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Sermorelin, Tesamorelin). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (Sermorelin, Tesamorelin). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (Sermorelin, Tesamorelin). Monitor accordingly.

Frequently Asked Questions

Can I take Sermorelin with Tesamorelin?

Yes, but with caution. Similar mechanism; risk of excessive effects at higher doses. Regular monitoring is advised.

Is Sermorelin and Tesamorelin safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between Sermorelin and Tesamorelin?

Similar mechanism; risk of excessive effects at higher doses. This assessment has 90% confidence and is based on documented research data.

How should I time Sermorelin and Tesamorelin?

Sermorelin has a half-life of 10-12 minutes and Tesamorelin has a half-life of 26-38 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Sermorelin vs Tesamorelin

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.